This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Innovations of Karnewar Santosh in Antioxidant Compounds
Introduction
Karnewar Santosh is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of antioxidant compounds, particularly in relation to their anti-atherosclerotic effects. With a total of 2 patents to his name, Santosh is recognized for his innovative approaches to health-related inventions.
Latest Patents
One of his latest patents is focused on an antioxidant compound that exhibits an anti-atherosclerotic effect. This invention specifically relates to the synthesis of TPP+ coupled esculetin, also known as mitochondria-targeted esculetin (Mito-Esc). The biological evaluation of Mito-Esc demonstrates its ability to attenuate Angiotensin-II-induced atherosclerosis in apolipoprotein E knockout mice. Additionally, the invention explores the endothelial cell age-delaying effects of Mito-Esc, showcasing its potential in combating age-related vascular issues.
Career Highlights
Karnewar Santosh is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative scientific solutions.
Collaborations
He has collaborated with notable colleagues, including Kotamraju Srigiridhar and Vasamsetti Sathish Babu, to further enhance the impact of his research.
Conclusion
Karnewar Santosh's contributions to the field of antioxidant compounds highlight his dedication to scientific innovation and health improvement. His work not only advances the understanding of atherosclerosis but also opens new avenues for therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
